Product Code: RP-ID-10085828 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10085828
Market Overview:
Opioids Market Segmentation by Application (Anesthesia, Pain Relief, Diarrhea Suppression, Cough Suppression, and Others); by Receptor Binding (Strong Agonists, and Mild to Moderate Agonists); and by Product Type (Codeine, Oxycodone, Morphine, Fentanyl, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Global Opioids Market Highlights Over 2022- 2031
The global opioids market is estimated to grow at a ~4% CAGR over the forecast period, i.e., 2022 – 2031. Moreover, the market registered a revenue of approximately USD 20.0 billion in 2021. The growth of the market can be attributed to an increase in the demand for products for the treatment of pain, diarrhea, and cough. Moreover, there has been an increase in patients having severe pain from cancer, and in order to get relief from the pain opioids are safely prescribed to patients. As per the World Health Organization, cancer new cases increased by 19.3 million, accounting for 10 million deaths in 2020. Moreover, a rise in the number of surgeries is anticipated to surge the growth of the global opioids market.
GET A SAMPLE COPY OF THIS REPORT
The global opioids market is segmented by application into anesthesia, pain relief, diarrhea suppression, cough suppression, and others. Out of these, the pain relief segment is anticipated to hold the largest share over the forecast period in the global opioids market. This can be attributed to the increase in the percentage of people experiencing a high level of pain in their day-to-day lives. Moreover, there has been a rise in the number of death cases with a surge in the level of pain in the patients.
Global Opioids Market Regional Synopsis
Regionally, the global opioids market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in the North America region is anticipated to hold the largest share over the forecast period owing to the advanced infrastructure for the research and development of drugs for the treatment of patients. Moreover, the market in the Asia Pacific region is estimated to witness modest growth over the forecast period on the back of a rise in the percentage of people dealing with cancer and an increase in the population. Furthermore, as per the National Institute of Cancer Prevention and Research, approximately 2.25 million people in India are living with cancer.
Market Segmentation
Our in-depth analysis of the global opioids market includes the following segments:
By Application
-
Anesthesia
-
Pain Relief
-
Diarrhea Suppression
-
Cough Suppression
-
Others
By Receptor Binding
-
Long Acting
-
Short Acting
By Product Type
-
Codeine
-
Oxycodone
-
Morphine
-
Fentanyl
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Opioids Market
Growth Drivers
-
Increase in the demand for products for the treatment of pain, diarrhea, and cough.
-
Rise in the number of surgeries
-
Increase in patients suffering from cancer pain
Challenges
-
Lack of awareness related to the use of opioids
-
Increase in the side effects from the usage of opioids for the treatment
Key Companies Dominating the Global Opioids Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global opioids market that are included in our report are Pfizer Inc., Janssen Global Services, LLC, (Johnson & Johnson), Teva Pharmaceutical Industries Ltd., Purdue Pharma L.P., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC., AbbVie Inc., BIOGEN INC., Hikma Pharmaceuticals PLC, Bayer AG, and others.
Latest Developments in the Global Opioids Market:
-
30 July 2019: Pfizer Inc. announced the acquisition of Array BioPharma Inc., which is advancing breakthrough science for the discovery, development, and commercialization of targeted small molecule medicines to treat cancer and other diseases with high unmet needs.
-
4 August 2021: Hikma Pharmaceuticals PLC, announced the availability of KLOXXADOTM (naloxone HCl) nasal spray 8mg in the United States. The US Food and Drug Administration (FDA) approved KLOXXADOTM for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory and/or central nervous system depression in adult and pediatric patients.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the client's requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Pfizer Inc.
- Janssen Global Services LLC (Johnson & Johnson)
- Teva Pharmaceutical Industries Ltd.
- Purdue Pharma L.P.
- Sun Pharmaceutical Industries Ltd.
- Amneal Pharmaceuticals LLC.
- AbbVie Inc.
- BIOGEN INC.
- Hikma Pharmaceuticals PLC
- Bayer AG
Related Reports
Proof of Quality & Reliability
